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Abstract.
PURPOSE: A systematic literature review was conducted to determine best practice conservative management of pediatric
lymphoedema.
METHOD: The PRISMA protocol was followed; a search of Ovid Medline, Cinahl and Scopus was conducted using the search
terms children OR pediatric OR adolescent AND lymphoedema OR lymphedema. Studies about management or treatment of
lymphoedema in children were included while studies about filariasis, imaging, pathology, secondary lymphoedema, surgical
techniques, central lymphoedema and those with participants with a median age greater than 18 years were excluded.
RESULTS: Of 738 possible studies identified, eight studies were eligible for inclusion in the review: four case reports, two
retrospective service reviews and two prospective studies investigating different interventions. All studies were rated using the
NHMRC hierarchy of evidence and appraised by both authors using theMcMaster University Critical Review Form. Studies were
of low quality with poor descriptions of management, small sample size, unclear and inconsistent methodology and irreproducible
outcome measures.
CONCLUSION: This review identified low level evidence to support the use of pneumatic compression in the management of
pediatric lymphoedema. Further research is required to identify optimal parameters for application of pneumatic compression
and to investigate the use of other interventions for conservative management of pediatric lymphoedema.
Keywords: Lymphoedema, pediatric, therapeutics, management: self-management, disease-management
1. Introduction
Primary lymphoedema occurs due to a developmen-
tal lymphatic abnormality, which may appear at birth,
during childhood, adolescence, or even much later in
life. In contrast, secondary lymphoedema occurs as a
result of damage to the lymphatic system most fre-
quently due to cancer and its treatment, or filariasis,
a parasitic infection, which occurs in many tropical
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Victoria 3002, Australia. Tel.: +61 3 8458 4990; Fax: +61 3 8458
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countries. Primary lymphoedema has been estimated
to occur in approximately 1 in 6000 children; this fig-
ure is based on the report of a London clinic, nearly 30
years ago [1] and no more recent report of prevalence
has been published. Paediatric lymphoedema differs
from adult lymphoedema in several ways: it is com-
monly of primary origin [2], depending on the malfor-
mation may involve more than one limb or body area
and pitting oedema is not always present [3].
Although children with lymphoedema are estimated
to be few in number, the impact on their lives and that
of their families is large as parents struggle to man-
age the psychological and financial impact of lym-
phoedema and worry about the long term implications
for their child [4,5]. Diagnosis of lymphoedema is of-
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ten delayed: a review of services for people of any
age having lymphoedema in Victoria, Australia found
that it took an average of 9.4 years for those with pri-
mary lymphoedema to be diagnosed, in contrast to an
average of 1.5 years for those with secondary lym-
phoedema [6]. The National Lymphoedema Practition-
ers Register, established by the Australasian Lymphol-
ogy Association (ALA) in 2010, provides a list of lym-
phoedema practitioners who fulfil ALA accreditation
criteria. Out of a total of 168 lymphoedema therapists
in rural and metropolitan, private and public services,
only 27 (16%) are listed as treating children [7].
Historic literature describing management of pedi-
atric lymphoedema indicates that treatment has long
been based on the principles of adult management and
applied using a recipe approach [3,8,9] because it was
not considered that diagnostic measures would alter
treatment [9]. Compression, diuretics, surgery and no
treatment were all adult treatment options described
for children in the 1980s [9].
In the 21st century, management strategies for adult
lymphoedema evolved and have been applied to pe-
diatric management; these currently include skin care,
exercise, manual lymphatic drainage (MLD), use of
medication to control infections and compression ther-
apy [2,10,11]. Genetic phenotyping for diagnosis,
management and follow-up has been recommended
for children with no systemic involvement and for
those with systemic involvement a multidisciplinary
management approach,which includes both geneticists
and pediatricians, has been recommended [2]. While
a commentary paper by Schook et al. [11] provides a
flow chart for management of pediatric lymphoedema
it was based on research completed with adults who
had secondary lymphoedema. It has also been sug-
gested that pediatric specific management strategies in-
cluding teaching parents to participate in management,
encouraging normal physical activity and the impor-
tance of psychological support and self-management
are required for optimal outcomes [2].
Compression therapy has been consistently descri-
bed to manage pediatric lymphoedema with reports
from small populations indicating that its use may have
increased from 46% in 1985 [9] to 75.4% in 2011 [11].
The type of compression described has altered from
compression garments and bandaging – either alone or
in combination with diuretics – in 1985 [9] to pneu-
matic compression, and “controlled compression ther-
apy: custom-fitted layered stockings that are progres-
sively tightened” in 2011 [11].
Manual lymphatic drainage has long been recom-
mended for treatment of adult lymphoedema [12,13]
but was not described for pediatric lymphoedemaman-
agement until more recently with the acknowledge-
ment there was a lack of evidence for its use in chil-
dren [2].
While there seems to be variation in management of
pediatric lymphoedema according to the therapist and
their country, guidelines for pediatric lymphoedema
management are non-existent. An international con-
sensus document on ‘Best practice for the management
of lymphoedema’ has no mention of children [14] and
a pediatric Lymphoedema Framework document de-
veloped in 2010 provides advice regarding access, di-
agnosis and service provision but does not provide any
guidelines for physical treatment [15].
This systematic review was undertaken to identify
and assess the evidence regarding conservative physi-
cal management of pediatric lymphoedema.
2. Methods
In undertaking this literature review, the Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) protocol was followed [16],
which may be accessed at www.prisma-statement.org.
The review has PROSPERO registration, number CRD
42012003260.
2.1. Search strategy
A search of Medline, Scopus and Cinahl was under-
taken on 14th February 2014 using the search terms
and limits in Fig. 1. Reference lists of key articles and
literature reviews were hand searched for further eli-
gible articles and citations of these articles were then
searched for other appropriate articles. A search of the
indices of the Journal of Lymphoedema, established in
2006, was undertaken as this journal is an important
journal in the field and does not appear in the databases
searched.
2.2. Inclusion criteria and study characteristics
Children were defined by an upper age limit of
18 years. Studies were selected on the basis of con-
servative or physical therapy for lymphoedema where
the study population was children or included children
and the results for children were reported separately
and management or therapy or treatment appeared in
the title or abstract, or a physical treatment method was
specified. Case studies were also included unless it was
clear from the abstract that no management was inves-
tigated or they were exclusively diagnostic.
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1. Lymphedema* OR "milroy disease" OR "nonne-milroy-meige disease" OR "nonne-milroy 
lymphedema" OR "nonne milroy" OR "milroy's disease" OR "milroys disease" OR 
lymphoedema* OR elephantias* OR "verrucosis lymphostatic" OR "mossy foot" OR 
"microcrystal diseases" OR "lymphostatic verrucoses" OR "microcrystal disease" OR 
"diseases microcrystal" OR "lymphostatic verrucosis" OR "bigfoot disease" OR "bigfoot 
diseases" OR "verrucoses lymphostatic" OR "mossy foots" OR "Lymphatic System 
Abnormalities" OR "Lymph System Abnormalities" 
2. Treatment* OR therap* OR manage* 
3. Child* OR youth* OR adolesce* OR infant* OR toddler* OR teen* 
4. 1 AND 2 AND 3. 
5. Limit 4 to English and Human 
6. 5 not filaria*.mp 
Fig. 1. Search terms 14th February 2014 (Ovid Medline, Cinahl and Scopus).
Records identified through 
database searching  
(n = 202+7+529=738) 
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Full-text articles assessed 
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Studies included in 
qualitative synthesis  
(n =8)
Fig. 2. Prisma flow diagram of literature search16 .
2.3. Exclusion criteria
Studies were excluded if they were about secondary
or genital lymphoedema, or surgical management. Let-
ters and editorials were also excluded. A flow chart de-
picting the process for inclusion and exclusion is pro-
vided in Fig. 2.
Included studies were ranked using the National
Health and Medical Research Council (NHMRC) hier-
archy of evidence (Level I systematic review of level
II studies, Level II a randomized controlled trial, Level
III-1 a pseudo-randomized controlled trial, Level III-
2 a comparative study with concurrent controls, Level
III-3 a comparative study without concurrent controls
and Level IV case series) and appraised using the Mc-
Master University Critical Review Form [17].
3. Results
The searches returned a total of 738 studies for pos-
sible inclusion. A search of the indices of the Journal
of Lymphoedema identified a further two papers and
examination of reference lists of the most relevant, a
further seven papers. Sixteen duplicates were removed;
screening of the remaining studies via title and abstract
364 J.J. Phillips and S.J. Gordon / Conservative management of lymphoedema in children: A systematic review
Ta
bl
e
1
St
ud
y
co
m
pa
ris
on
ta
bl
e
A
ut
ho
r,
st
ud
y
ty
pe
,
se
tti
ng
Pa
rt
ic
ip
an
ts
M
an
ag
em
en
t/
In
te
rv
en
tio
n
O
ut
co
m
e
m
ea
su
re
s
St
at
is
tic
al
an
al
ys
is
R
es
ul
ts
L
im
ita
tio
ns
A
le
xa
nd
er
et
al
.[
21
]
C
as
e
re
po
rt
D
T
W
at
so
n
R
eh
ab
ili
ta
tio
n
H
os
pi
ta
lf
or
C
hi
ld
re
n
Pe
nn
sy
lv
an
ia
U
SA
9
yr
ol
d
fe
m
al
e
Pa
rk
-W
eb
er
Sy
nd
ro
m
e
R
U
L
+R
L
L
8
ho
ur
s
us
e
of
L
in
ea
r
Pu
m
p
ov
er
ni
gh
t+
us
e
of
C
G
du
ri
ng
th
e
da
y
fo
r4
/1
2
12
C
M
:
4
fo
ot
/4
kn
ee
/
4
kn
ee
to
up
pe
r
th
ig
h.
D
ia
-
gr
am
pr
ov
id
ed
.
C
ha
ng
e
in
C
M
=
pr
e
C
M
le
ss
po
st
C
M
/(
pr
e
C
M
le
ss
C
M
of
no
rm
al
le
g)
D
es
cr
ip
tiv
e
re
su
lts
R
ed
uc
tio
n
of
53
%
m
id
-
th
ig
h,
70
%
m
id
-c
al
f
an
d
27
%
fo
ot
ar
ch
at
4/
12
C
om
pa
ra
to
r
no
td
es
cr
ib
ed
,
no
bl
in
di
ng
of
as
se
ss
or
s.
C
oi
nc
id
en
ta
lu
se
of
C
G
A
ve
ry
et
al
.[
22
]
C
as
e
re
po
rt
M
on
tg
om
er
y
H
os
pi
ta
l,
Pe
nn
sy
lv
an
ia
U
SA
5/
12
ol
d
m
al
e
C
on
ge
ni
ta
l
R
L
L
L
O
O
ns
et
4/
12
ol
d
U
se
of
pn
eu
m
at
ic
co
m
pr
es
si
on
fo
r2
/1
2
C
M
at
fo
ot
ar
ch
,
an
kl
e,
m
id
-c
al
f
an
d
in
fe
rio
r
kn
ee
at
ba
se
lin
e,
12
,2
8,
40
an
d
63
da
ys
D
es
cr
ip
tiv
e
re
su
lts
A
t2
/1
2
R
ed
uc
tio
n
C
M
3
cm
at
an
kl
e
an
d
1
cm
m
id
-c
al
f
In
cr
ea
se
C
M
1.
5
cm
at
fo
ot
an
d
3.
5
cm
be
lo
w
kn
ee
N
o
cl
in
ic
al
ly
re
le
va
nt
ch
an
ge
de
fin
ed
.
N
o
lo
ng
te
rm
fo
llo
w
-u
p.
U
se
of
un
af
fe
ct
ed
lim
b
as
co
m
pa
ra
to
r
A
kb
ay
ra
k
et
al
.[
24
]
C
as
e
re
po
rt
H
ac
et
te
pe
U
ni
ve
rs
ity
Sc
ho
ol
of
Ph
ys
ic
al
T
he
ra
py
an
d
R
eh
ab
ili
ta
tio
n,
A
nk
ar
a,
Tu
rk
ey
6.
5/
12
fe
m
al
e
C
on
ge
ni
ta
l,
B
iL
L
O
ns
et
2/
12
ol
d
Ph
ys
io
th
er
ap
is
ta
pp
lie
d
M
L
D
,m
ul
ti-
la
ye
re
d
co
m
pr
es
si
on
ba
nd
ag
in
g.
5
da
ys
/w
k
fo
r2
.5
/1
2
H
om
e
pr
og
ra
m
re
m
ed
ia
l
ex
er
ci
se
s
an
d
sk
in
ca
re
by
m
ot
he
rd
ur
in
g
2.
5/
12
an
d
af
te
r.
C
M
at
2
cm
in
te
rv
al
s
an
kl
e
to
10
cm
ab
ov
e
th
e
kn
ee
W
at
er
di
sp
la
ce
m
en
t
–
no
de
sc
rip
tio
n.
M
ea
su
re
m
en
t
pr
e-
,
2.
5/
12
(e
nd
of
in
te
rv
en
tio
n)
+
6/
12
po
st
in
te
rv
en
tio
n
D
es
cr
ip
tiv
e
re
su
lts
C
M
an
d
vo
lu
m
et
ric
m
ea
-
su
re
s
“r
efl
ec
te
d
re
du
ct
io
n
in
sw
el
lin
g”
af
te
r
2.
5/
12
T
T
an
d
at
6/
12
po
st
T
T
N
o
de
sc
rip
tio
n
of
“e
xe
rc
i-
se
or
ho
m
e
pr
og
ra
m
”
fo
r
a
6/
12
ba
by
.
L
im
ite
d
de
-
sc
rip
tio
n
of
in
te
rv
en
tio
n
an
d
co
nt
ro
lm
ea
su
re
s.
N
o
co
ns
id
er
at
io
n
of
a
cl
in
-
ic
al
ly
re
le
va
nt
ch
an
ge
M
ah
ra
m
et
al
.[
23
]
C
as
e
re
po
rt
Q
az
vi
n,
Ir
an
.
15
ye
ar
ol
d
fe
m
al
e
L
O
pr
ae
co
x
R
L
L
U
se
of
4
L
L
LT
pr
ob
es
(w
av
e-
le
ng
th
63
0
or
89
0
nm
)
Pr
ob
es
an
d
po
si
tio
ns
de
sc
rib
ed
.
T
T
cy
cl
e
of
12
T
T
se
ss
io
ns
(o
n
al
te
rn
at
e
da
ys
,o
ve
r
1/
12
)
w
ith
1/
12
re
st
th
en
a
se
co
nd
cy
cl
e
of
1/
12
C
M
ju
st
be
lo
w
th
e
kn
ee
,
15
cm
be
lo
w
th
e
kn
ee
an
d
ab
ov
e
th
e
an
kl
e
D
es
cr
ip
tiv
e
re
su
lts
D
ec
re
as
e
of
2
cm
be
lo
w
th
e
kn
ee
,2
cm
at
th
e
an
kl
e
an
d
4
cm
at
15
cm
be
lo
w
th
e
kn
ee
af
te
r
th
e
2n
d
in
-
te
rv
en
tio
n
cy
cl
e.
N
o
si
de
ef
fe
ct
no
te
d
du
r-
in
g
T
T.
N
o
si
gn
ifi
ca
nt
in
cr
ea
se
in
C
M
th
re
e
m
on
th
s
af
te
r
in
-
te
rv
en
tio
n
ce
as
ed
N
o
in
fo
rm
at
io
n
re
ga
rd
in
g
bl
in
di
ng
of
as
se
ss
or
s
or
pr
ot
oc
ol
of
as
se
ss
m
en
t.
N
o
da
ta
pr
ov
id
ed
at
3
m
on
th
s
af
te
r
in
te
rv
en
tio
n
(d
is
cu
ss
ed
in
re
po
rt
)
J.J. Phillips and S.J. Gordon / Conservative management of lymphoedema in children: A systematic review 365
Ta
bl
e
1,
co
nt
in
ue
d
A
ut
ho
r,
st
ud
y
ty
pe
,
se
tti
ng
Pa
rt
ic
ip
an
ts
M
an
ag
em
en
t/
In
te
rv
en
tio
n
O
ut
co
m
e
m
ea
su
re
s
St
at
is
tic
al
an
al
ys
is
R
es
ul
ts
L
im
ita
tio
ns
D
e
G
od
oy
et
al
.[
19
]
Pr
os
pe
ct
iv
e
C
as
e
R
ep
or
t
20
04
–2
00
9
G
od
oy
C
lin
ic
,
Sa
o
Jo
se
do
R
io
Pr
et
o,
B
ra
zi
l
In
cl
us
io
n
cr
ite
-
ria
:
cl
in
ic
al
di
-
ag
no
si
s
L
L
L
O
by
C
M
at
2
po
in
ts
on
th
e
fe
et
9
m
al
es
,
5
fe
m
al
es
(N
=
14
)
A
ge
ra
ng
e:
2/
12
to
8.
5
yr
s
G
ro
up
1
(N
=
10
)
G
ro
up
2
(N
=
4)
pa
rt
ic
ip
an
ts
ha
d
fib
ro
si
s,
L
O
>
3
yr
s
G
ro
up
1c
er
vi
ca
ls
tim
ul
at
io
n
G
ro
up
2
ce
rv
ic
al
st
im
ul
at
io
n
+
C
G
s
M
ot
he
rs
tra
in
ed
in
m
an
ua
lc
er
-
vi
ca
ls
tim
ul
at
io
n
te
ch
ni
qu
e
ap
-
pl
ie
d:
15
–2
0
m
in
s/
da
y
20
–3
0
st
im
ul
i/m
in
ut
e.
In
te
rv
en
tio
n
pe
ri
od
2
ye
ar
s
20
04
–2
00
9
Fo
llo
w
ed
fo
r2
ye
ar
s
C
M
:f
ee
ta
t3
cm
an
d
6
cm
su
pe
rio
r
to
th
e
ba
se
of
th
e
bi
g
to
e.
2-
ta
ile
d
t-
te
st
an
d
W
ilc
ox
on
’s
m
at
ch
ed
pa
ir
te
st
A
lp
ha
er
ro
ro
f5
%
(P
<
0.
05
)
ac
ce
pt
ab
le
G
ro
up
1
Pr
e
be
tw
ee
n
fe
et
p
<
0.
00
01
Po
st
be
tw
ee
n
fe
et
p
<
0.
02
Pr
e
to
po
st
sa
m
e
fo
ot
p
=
0.
00
01
G
ro
up
2
Pr
e
be
tw
ee
n
fe
et
p
<
0.
00
02
Po
st
be
tw
ee
n
fe
et
p
<
0.
08
Pr
e
to
po
st
sa
m
e
fo
ot
p
<
0.
00
2
N
o
be
tw
ee
n
gr
ou
p
an
al
ys
is
C
on
fo
un
di
ng
of
re
su
lts
by
in
di
sc
rim
in
at
e
se
le
ct
iv
e
ad
di
tio
n
of
ot
he
rf
or
m
s
of
T
T
in
cl
ud
in
g
m
an
ua
l
an
d
m
ec
ha
ni
ca
ll
ym
ph
dr
ai
na
ge
du
rin
g
th
e
tri
al
.
H
as
sa
ll
et
al
.[
25
]
R
et
ro
sp
ec
tiv
e
re
vi
ew
re
co
rd
s
fr
om
19
87
–1
99
7
T
he
H
os
pi
ta
lf
or
Si
ck
C
hi
ld
re
n,
To
ro
nt
o
C
an
ad
a
7
m
al
e,
9
fe
m
al
e
A
ge
ra
ng
e
A
td
ia
gn
os
is
0.
1–
14
yr
s
St
ar
t0
.8
–1
6
yr
s
E
nd
6–
26
yr
s
Pr
im
ar
y
or
se
c-
on
da
ry
L
O
U
L
3
U
i
L
L
7
U
i
L
L
6
B
i
E
xc
lu
si
on
:
va
sc
ul
ar
in
vo
lv
em
en
t
Pn
eu
m
at
ic
co
m
pr
es
si
on
pu
m
p,
w
ea
ri
ng
C
G
s
an
d
ad
vi
ce
on
ex
-
er
ci
se
an
d
sk
in
hy
gi
en
e.
Pu
m
p
pr
es
su
re
T
T
ph
as
e
50
–1
40
m
m
H
g
M
ea
n
84
.2
9
±
24
.7
2
m
m
H
g.
M
ai
nt
en
an
ce
ph
as
e
35
–1
00
m
m
H
g
M
ea
n
58
.5
7
±
19
.0
5
m
m
H
g
C
M
7
po
in
ts
L
L
:
gr
oi
n,
th
ig
h,
ca
lf
,3
cm
ab
ov
e
an
d
at
th
e
an
kl
e,
m
id
fo
ot
an
d
to
es
8
po
in
ts
U
L
:a
xi
lla
ry
fo
ld
,
m
id
an
d
lo
w
er
up
pe
r
ar
m
,e
lb
ow
cr
ea
se
,m
id
an
d
lo
w
er
fo
re
ar
m
,w
ris
t
cr
ea
se
an
d
ha
nd
.
W
at
er
di
sp
la
ce
m
en
t
to
th
e
gr
oi
n;
>
10
%
di
ff
er
en
ce
si
gn
ifi
ca
nt
Pa
ire
d
t-t
es
ts
p
<
0.
05
si
g-
ni
fic
an
t;
C
Ib
as
ed
on
ex
pe
rt
op
in
-
io
n
U
iL
O
C
M
>
5%
ch
an
ge
C
I
<
5%
ch
an
ge
M >
−5
%
ch
an
ge
D
U
iL
O
Vo
lu
m
e
>
10
%
ch
an
ge
C
I
<
10
%
ch
an
ge
M
>
−1
0%
ch
an
ge
D
B
iL
O
T
hi
gh
to
fo
ot
ra
tio
ch
an
ge
>
2
=
C
I
20
%
lim
bs
C
I,
73
%
M
,
7
%
D
In
cr
ea
se
d
pu
m
p
pr
es
su
re
,
in
iti
al
vs
en
d
p
=
0.
00
36
Vo
lu
m
e,
C
M
an
d
ra
tio
pr
e
an
d
po
st
T
T
–
no
st
at
is
tic
al
di
ff
er
en
ce
N
o
co
m
pl
ic
at
io
ns
in
88
%
,
2
(1
2%
)
co
m
pl
ic
at
io
ns
:
1
ce
llu
lit
is
/
1
pr
es
su
re
so
re
on
he
el
in
a
pa
tie
nt
w
ith
ce
re
br
al
pa
ls
y
U
se
of
un
af
fe
ct
ed
lim
b
as
co
m
pa
ra
to
r.
V
ar
ia
tio
n
in
T
T
du
ra
tio
n
fr
om
19
–9
6/
12
M
T
T
va
rie
d
fr
om
2–
8
tim
es
pe
rw
ee
k;
ho
ur
so
fT
T
va
rie
d
fr
om
1–
8
ho
ur
s
pe
rd
ay
366 J.J. Phillips and S.J. Gordon / Conservative management of lymphoedema in children: A systematic review
Ta
bl
e
1,
co
nt
in
ue
d
A
ut
ho
r,
st
ud
y
ty
pe
,
se
tti
ng
Pa
rt
ic
ip
an
ts
M
an
ag
em
en
t/
In
te
rv
en
tio
n
O
ut
co
m
e
m
ea
su
re
s
St
at
is
tic
al
an
al
ys
is
R
es
ul
ts
L
im
ita
tio
ns
H
ut
zs
ch
en
re
ut
er
an
d
H
er
-
pe
rt
z
[2
6]
R
et
ro
sp
ec
tiv
e
re
vi
ew
da
te
s
un
sp
ec
ifi
ed
19
83
–1
99
2
lik
el
y
U
ni
ve
rs
ity
of
U
lm
,
G
er
m
an
y
N
=
50
,4
3
pr
i-
m
ar
y
&
7
se
c-
on
da
ry
L
O
A
ge
ra
ng
e:
3/
12
–1
6
ye
ar
s
12
pr
im
ar
y
he
re
di
ta
ry
:
L
L
7
B
i/U
L
3
B
i/
4
lim
bs
/H
al
f
bo
dy
1
31
pr
im
ar
y
sp
or
ad
ic
:
L
L
16
B
i
L
L
11
U
i
U
L
2
U
i
U
L
+
fa
ce
1
U
L
+
B
iL
L
1
In
pa
tie
nt
4/
52
<
2
yr
s
ol
d:
M
L
D
tw
ic
e/
da
y
>
2
yr
s
ol
d:
M
L
D
tw
ic
e/
da
y
pl
us
co
m
pr
es
si
on
ba
nd
ag
in
g.
M
T
M
C
G
at
en
d
of
T
T.
Sh
or
t
“s
tre
ss
”
ba
nd
ag
es
us
ed
fo
rc
om
pr
es
si
on
ba
nd
ag
in
g.
M
ea
su
re
s
ta
ke
n
pr
e
+
4/
52
(p
os
t)
Vo
lu
m
es
ca
lc
ul
at
ed
us
in
g
K
uh
nk
e
m
et
ho
d:
th
e
vo
l-
um
e
of
a
4
cm
se
gm
en
to
f
a
lim
b
is
V
=
c
2
4
π
an
d
th
e
vo
lu
m
e
of
a
w
ho
le
lim
b
is
=
Σ
c
2
π
.
L
eg
vo
lu
m
e
ch
an
ge
pr
e
an
d
po
st
W
ilc
ox
on
m
at
ch
ed
pa
irs
te
st
Pr
im
ar
y
ar
m
an
d
se
co
nd
ar
y
(d
ue
va
ria
bl
e
si
te
s)
vo
lu
m
e
ch
an
ge
de
sc
rip
tiv
e
re
su
lts
du
e
to
sm
al
l
nu
m
be
rs
D
es
cr
ip
tio
n
by
lim
b
do
m
in
an
ce
Pr
im
ar
y
B
iL
O
re
du
ct
io
n
(R
le
g
do
m
in
an
t)
(p
<
0.
02
5)
;
R
U
i
L
O
un
af
fe
ct
ed
L
le
g
re
du
ct
io
n
in
vo
lu
m
e
p
<
0.
05
A
rm
or
le
g
vo
lu
m
e
de
-
cr
ea
se
N
=
47
(9
4%
)
N
o
ef
fe
ct
in
3
U
L
w
ith
ly
m
ph
an
gi
om
a
cy
st
ic
us
.
D
iffi
cu
lt
to
in
te
rp
re
t
gr
ap
hs
pr
ov
id
ed
.
N
o
ta
bl
e
of
re
su
lts
N
o
de
sc
ri
pt
io
n
of
m
et
ho
d
N
o
co
nc
lu
si
on
s
pr
ov
id
ed
th
at
ar
e
pe
rt
in
en
tt
o
th
e
re
-
su
lts
M
cL
eo
d
et
al
.[
20
]
Pr
os
pe
ct
iv
e
st
ud
y
T
he
H
os
pi
ta
l
fo
r
Si
ck
C
hi
ld
re
n,
To
ro
nt
o
C
an
ad
a
7
gi
rls
2
bo
ys
8
co
ng
en
ita
l
L
O
;
1
se
co
nd
ar
y
to
H
od
gk
in
s
ly
m
ph
om
a
an
d
X
RT
;
6
R
L
L
3
L
L
L
M
ea
n
ag
e
of
on
se
t:
2.
6
yr
s
(r
an
ge
0–
14
);
M
ea
n
ag
e
at
st
ar
to
fs
tu
dy
:
13
yr
s
(r
an
ge
5.
5–
17
)
C
om
pa
ris
on
3
Pn
eu
m
at
ic
C
om
pr
es
si
on
de
vi
ce
s
W
ri
gh
tL
in
ea
rP
um
p:
M
Ps
85
/6
5/
45
di
st
al
to
pr
ox
i-
m
al
ov
er
th
e
le
ng
th
of
th
e
pn
eu
-
m
at
ic
sl
ee
ve
;
Ly
m
ph
a-
Pr
es
s :
M
P1
22
.5
m
m
H
g
H
em
afl
o
2 :
M
P:
43
m
m
H
g
T
T:
2/
7
be
d
re
st
,e
le
va
tio
n,
pu
m
p
on
2/
24
,o
ff
0.
5/
24
N
ig
ht
:6
/2
4
pu
m
p.
H
om
e
pr
og
ra
m
ov
er
ni
gh
t
pu
m
p
+
da
ily
5
m
in
ut
es
st
ep
up
ex
er
ci
se
s
+
C
G
C
M
2/
3
di
st
an
ce
m
ed
ia
l
m
al
le
ol
us
to
ba
se
of
pa
te
lla
pe
rS
w
ed
bo
rg
3
8
.
Vo
lu
m
et
ri
c
m
ea
su
re
s
–
ba
se
of
th
e
pa
te
lla
(w
ith
le
g
ex
te
nd
ed
)
%
in
cr
ea
se
in
vo
lu
m
e
or
C
M
co
m
pa
re
d
to
no
rm
al
lim
b
M
ea
su
re
d
pr
e-
T
T;
on
re
le
as
e
fr
om
ho
sp
ita
l;
at
1,
2, 3,
4,
12
,1
8
an
d
24
m
on
th
s
D
es
cr
ip
tiv
e
st
at
is
tic
s
Vo
lu
m
et
ri
c
re
du
ct
io
n
in
al
l
(N
=
9)
;
G
re
at
er
de
cr
ea
se
s
in
vo
l-
um
e
an
d
C
M
no
te
d
w
ith
Ly
m
ph
a-
Pr
es
s
(N
=
3)
A
ck
no
w
le
dg
em
en
t
of
ef
-
fe
ct
of
be
d
re
st
an
d
lim
-
ita
tio
ns
of
us
in
g
in
di
re
ct
m
et
ho
d
of
m
ea
su
re
m
en
t
–
us
in
g
gi
rt
h
C
M
to
ca
lc
u-
la
te
L
L
vo
lu
m
e
H
em
afl
o
2u
ni
ts
br
ok
e
af
te
r
4/
12
;
3
su
bj
ec
ts
tra
ns
fe
rr
ed
to
Ly
m
ph
a-
Pr
es
s
N
o
de
sc
ri
pt
io
n
of
ra
nd
om
is
at
io
n
L
im
ite
d
in
fo
rm
at
io
n
co
-in
te
rv
en
tio
ns
(e
xe
rc
is
e,
C
G
s)
R
es
ul
ts
in
co
m
pl
et
e;
no
ex
-
pl
an
at
io
n
of
pa
tie
nt
lo
ss
pr
ov
id
ed
.
U
se
of
un
af
fe
ct
ed
lim
b
as
co
nt
ro
l.
L
eg
en
d:
L
O
=
ly
m
ph
oe
de
m
a;
U
L
=
U
pp
er
lim
b;
L
L
=
L
ow
er
lim
b.
C
I=
cl
in
ic
al
im
pr
ov
em
en
t,
M
=
m
ai
nt
en
an
ce
,D
=
de
te
rio
ra
tio
n,
C
M
=
C
irc
um
fe
re
nt
ia
lm
ea
su
re
,B
i=
B
ila
te
ra
l,
U
i=
U
ni
la
te
ra
l,
T
T
=
tr
ea
tm
en
t,
C
G
=
co
m
pr
es
si
on
ga
rm
en
t,
M
P
=
M
ea
n
pr
es
su
re
.
J.J. Phillips and S.J. Gordon / Conservative management of lymphoedema in children: A systematic review 367
Table 2
Evaluation questions – quantitative studies critical appraisal tool
(McMaster)
1. Was the study purpose stated clearly?
2. Was relevant background literature reviewed?
3. Was the design appropriate for the study question?
4. Was the sample described in detail?
5. Was the sample size justified?
6. Were the outcome measures valid?
7. Were the outcome measures reliable? (Threats to internal
validity controlled?)
8. Was the intervention described in detail?
9. Was contamination avoided?
10. Was co-intervention avoided?
11. Were the results reported in terms of statistical significance?
12. Was the analysis method appropriate?
13. Were the conclusions appropriate given study methods and
results?
14. Were the main limitations and biases discussed?
excluded 628 studies; these consisted of those on filar-
iasis, genetics, case studies (descriptive or diagnostic),
imaging, pathology (including physiology and anatom-
ical descriptions), surgery (as a treatment for lym-
phoedema), cancer and surgery (as a cause of lym-
phoedema). The full-text of 101 papers were screened
(JJP) to assess for eligibility and any uncertainty re-
garding inclusion was discussed between the authors.
Articles excluded from this review included re-
cent research about management of pediatric lym-
phoedema,which has concentrated on the development
of an appropriate response to children within an adult
service [18], and the psychosocial support needed by
the families of children with lymphoedema [4,5].
Eight studies were appropriate to include in the re-
view. Two were prospective clinical reports: one inves-
tigated a newmanual massage technique [19] while the
other compared three different pneumatic compression
machines [20]. Four case studies were included with
two reporting the outcomes of pneumatic compres-
sion [21,22], one low level laser therapy [23] and an-
other bandaging of an infant’s legs [24]. The remaining
studies retrospectively evaluated the use of pneumatic
compression [25] and manual lymphatic drainage and
compression bandaging [26]. (See Table 1)
All studies were level III-3 or IV based on the
NHMRC hierarchy of evidence. Papers were assessed
by both authors for quality using the McMaster criti-
cal appraisal tool [17] (see Table 2). Where ratings dif-
fered between authors discussion occurred to arrive at
consensus. A score of one was allocated where the re-
sponse to the question was yes, a zero was allocated
where the answer was no or insufficient detail was pro-
vided. Where the question was not applicable to the
study type, the total score was reduced by one, and the
scores have therefore been presented as percentages to
enable comparison (see Table 3). The highest score for
a study was 67% [25] and the lowest was 14% [26].
4. Study description: Prospective studies
4.1. Intervention
Two different interventions for lower limb lym-
phoedema were investigated: manual cervical stimula-
tion [19] and comparison of three different pneumatic
compression devices [20]. The method and length of
intervention was not comprehensively described in ei-
ther study and were therefore not reproducible. Neither
study provided standardized intervention for each par
ticipant. During the compression study one machine
malfunctioned and that study group was allocated to a
different machine during the trial [20] while De Godoy
et al [19] inconsistently added other interventions to
the manual cervical stimulation during the trial. There-
fore any treatment outcomes reported by these studies
cannot be attributed to any specific intervention.
4.2. Sample characteristics
The sample sizes of the studies were small and no
sample size calculation or post-hoc power calculations
were provided. De Godoy et al. [19] provided lim-
ited description of participants, and while treating the
whole lower limb only feet measurements were re-
ported. Although, McLeod et al. [20] stated that the
mean age of onset and the mean age at commencement
of the study were similar across groups, on examina-
tion of the raw data there was a large variation [20].
4.3. Outcome measures
Random assignment to pneumatic compression in-
tervention groups was not described. Both studies used
the unaffected limb for comparison. Outcome mea-
sures used to assess lower limb lymphoedema var-
ied in type and measurement protocol between stud-
ies. De Godoy et al. [19] arbitrarily considered a two-
centimeter reduction in foot circumference as a signif-
icant change while the results presented by McLeod et
al. [20] are difficult to interpret due to poor description
of data management and results.
4.4. Findings
McLeod et al. [20] reported lower volumetric mea-
sures after 18 to 24 months of treatment no mat-
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Table 3
NHMRC ratings and McMaster critical appraisal ratings
First author L 1 2 3 4 5 6 7 8 9 10 11 12 13 14 TS %
Akbayrak <IV N N Y Y A Y Y N Y N A Y Y N 7/12 58
Alexander <IV Y Y Y Y D Y D Y N N N Y N N 7/14 50
Avery <IV N Y Y Y D Y D N D D N Y N N 5/14 36
De Godoy IV N N Y N N D D N N N Y Y N N 3/14 21
Hassall III-3 Y Y Y Y N Y N N A A Y Y Y N 8/12 67
Mahram <IV Y Y Y Y D Y D N D D N N Y N 6/14 43
McLeod III-3 Y Y Y N N Y N Y A D N N N N 5/13 38
Hutzschen-reuter III-3 Y N Y N N D D N D D Y N N N 2/14 14
TS 5 5 8 5 0 6 1 2 1 0 3 5 3 0
Legend: L= level of NHMRC evidence, Y= yes, N = no, D = not described, A = not applicable, TS= total score.
ter which pneumatic compression device was used.
However no attempt was made to relate the amount
of change in volumetric measure to a clinically rele-
vant change. The research primarily assessed the rel-
ative merits of each pneumatic machine and reported
that all were safe and easy to use. The authors also
concluded that pneumatic compression could alleviate
skin changes and improve quality of life; however they
did not include outcome measures that assessed either
skin change or quality of life.
The use of manual cervical stimulation was reported
to significantly reduce foot volume; however there was
considerable difference in treatment between individu-
als and non-random allocation to groups, which under-
mined conclusions about the efficacy of the interven-
tion [19].
5. Study description: Retrospective studies
5.1. Intervention
A case note audit was undertaken to assess the use
of pneumatic compression in pediatric lymphoedema
management [25] at the same hospital where the
prospective comparison of three pneumatic compres-
sion machines was conducted [20]. There were large
differences in the treatment duration (months), the
number of sessions per week during the maintenance
phase and the number of hours per day the compression
was applied. Ten years of patient care were reviewed
to assess the outcome of four weeks of inpatient MLD
and compression bandaging [26]. Children two years
and older were treated with MLD twice a day and com-
pression bandaging, while those under two years only
had MLD twice a day. No further description of the
intervention was given.
5.2. Sample characteristics
Sixteen children of both genders were included in
the study on pneumatic compression and were sub-
grouped into unilateral upper limb, unilateral lower
limb or bilateral lower limb lymphoedema, resulting
in sample sizes of three to seven in each group. Mean
age at diagnosis and commencement of treatment were
provided and by the end of the study the age range
extended over 18 years [25]. Fifty children (43 pri-
mary and 7 secondary) were included for analysis of
MLD and compression therapy [26], with an age range
of three months to 16 years. The majority of children
studied had one or both legs involved (37).
5.3. Outcome measures
Hassall et al. [25] provided details of initial pres-
sure setting, pressure reduction, treatment duration,
frequency per week of treatment or maintenance, and
hours per day of treatment. Circumferential measures
at seven points on the lower limb and eight points on
the upper limb as well as water displacement volume
to the groin or axilla were measured. Water displace-
ment measures were presented as a percentage change
in volume using the unaffected limb as the compara-
tor. A difference in volumetric percentage of greater
than 10% or less than minus 10% were considered to
be a clinically significant improvement or deteriora-
tion. Percentage change, which fell between 10% and
minus 10%, indicated maintenance of limb size. Cir-
cumferential measures at each point were summed and
the mean value used to calculate a percentage differ-
ence in limb circumference, using the unaffected limb
as the comparator. For those children with bilateral
lymphoedema the authors devised and applied a thigh
to foot ratio to calculate change in the absence of an
unaffected “control” limb. An increase in the ratio of
greater than two units was interpreted as a decrease
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in lymphoedema while a decrease of greater than two
units indicated an increase in lymphoedema. The au-
thors state that the level of clinical significance for all
measures in this study was set at an arbitrary point
deemed significant by an expert physical therapist and
physician in the absence of guidelines.
In contrast, no detail of outcome measure was given
by Hutzschenreuter and Herpertz [26], advising that
the measures were taken and calculated according to
the method devised by Kuhnke [27] and reported in
German in 1979 (in [26,28]) and that the measures
were taken at the pre- and post-treatment point as well
as the end of each week of the four weeks of treatment.
5.4. Findings
Although, Hassall et al. [25] found a trend towards
clinical improvement in limb size and volume with
pneumatic compression the statistical analysis was not
significant. However a statistically significant reduc-
tion in pump pressure between the initial and mainte-
nance periods of the study was reported; this indicated
less pressure was required over time to maintain limb
size but there is no definition, measure or parameter
provided to describe the transition to maintenance care.
The authors acknowledged the limitations of the study,
including the small sample size, and lack of reliability
and validity studies of outcome measures. Hutzschen-
reuter and Herpertz [26] found reductions in both lym-
phoedema and “healthy” leg volumes. While statistical
analysis was not provided, participants with secondary
lymphoedema were reported to have a larger reduction
in limb size than those with primary lymphoedema.
The results were not discussed; instead the authors pos-
tulated about the mode of fluid movement with manual
lymphatic drainage.
6. Study description: Case reports
1) A comprehensive physiotherapy program that in-
cluded MLD, remedial exercises, bandaging (by
both therapist and mother during treatment phase
and mother during follow-up) and skin care in-
formation for a six month old female with bi-
lateral lower limb lymphoedema was reported
by Akbayrak et al. [24]. Volumetric and circum-
ferential measures were reported pre- and post-
intervention, and at six month follow-up. A re-
duction in swelling was reported in circumfer-
ential measures post-intervention and volumetric
changes at six months follow-up, with measures
given for right and left limb. Control measures
for the right and left lower limb were included
in the results table, but it was unclear if these
were the pre-intervention measures. No specific
informationwas provided regarding the interven-
tion, or the method of volume calculation, ren-
dering the study not reproducible. The effect of
growth was not discussed, although six centime-
ters increase in height was reported. A reduction
in leg lymphoedema may be observed in some
children undergoing a growth spurt, where limb
length has increased over a short period (author’s
observation).
2) Alexander et al. [21] reported that the use of
a linear pneumatic compression pump overnight
for four months resulted in reductions in mid-
thigh, mid-calf and foot arch circumferential
measures in a nine-year-old female with Park-
Weber syndrome. However there was no blinding
of assessors or long term follow-up, and coinci-
dental use of compression garments indicate cau-
tion in attributing this outcome solely to pneu-
matic compression.
3) Five treatments of sequential pneumatic com-
pression were used by Avery et al. [22] over two
months, at intervals varying from 12 to 23 days
to treat a five month old male with congenital
lower limb lymphoedema. Results included de-
creased ankle andmid-calf but increased foot and
below knee circumferential measures. No detail
was provided regarding the method or timing of
application and hence this study is not repro-
ducible.
4) Low level laser therapy (LLLT) applied on al-
ternate days for 12 sessions to a 15-year-old fe-
male resulted in decreased limb circumference,
which was maintained three months after ces-
sation of treatment [23]. No side effects from
the use of LLLT were reported [23]; limitations
of this study include a variation in the dosage
reported, lack of information regarding prior or
concurrent management strategies and the lack
of long term follow-up.
7. Discussion
The eight studies that met the criteria for this re-
view provide poor quality, low level evidence (level
III-3 & IV) to guide the management of pediatric lym-
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phoedema. Small sample sizes and variability in par-
ticipant demography limited the power and decreased
the generalizability of the research findings.
Management of pediatric lymphoedema provides
different challenges due to the implications of nor-
mal growth, and childhood understanding and there-
fore cooperation with management practices. The clin-
ical presentation of primary lymphoedema may af-
fect many body parts depending on the malformation
within the lymphatic system. Properties of the tissues
differ with pediatric lymphoedema being described as
non-pitting [3]. Developmental changes require moni-
toring in both psychological and physical domains for
children [2].
Researchers have variously suggested that fungal in-
fections and cellulitis are less common in children than
adults [2,29]; or very common in children [19]. While
skin care to prevent infection has been a longstand-
ing, universally accepted management practice for sec-
ondary, adult lymphoedema, given the various opin-
ions regarding childhood susceptibility, it is not sur-
prising that only one recent study in this review in-
cluded preventative skin care measures [19]. However
avoidance of infections continues to be recommended
for pediatric lymphoedema management [2].
Due to the shorter duration of pediatric lymphoede-
ma, children have been reported to have less func-
tional impairment and malignant degeneration [11]
than the adult lymphoedema population. However this
is a broad generalization as pediatric lymphoedema
can be extremely debilitating. Exercise is important to
maintain function and in children, it can be challenging
to prescribe or manage the amount of exercise, partic-
ularly in preschool years. While the description of dif-
ferences in pediatric presentation is widespread there is
limited information about the underlying physiological
and tissue factors which contribute to these differences.
Without this knowledge the management approach is
likely to be sub-optimal and will continue to default to
adoption of adult management regimes.
The outcome measures used in the studies in this re-
view reflected the lack of international agreement re-
garding a standardized measurement protocol to mon-
itor limb size and volume. Due to the effect of nor-
mal growth a different approach to monitoring pedi-
atric lymphoedema is required [2,5]. In an adult, mon-
itoring of body weight and limb circumferential mea-
sures will identify if a limb is increasing in size, po-
tentially indicating worsening lymphoedema; whereas
in children there will be a natural increase in size due
to limb growth. The use of an unaffected limb as a
control to compare to the affected limb is common
practice both in research and clinically. Most studies
have compared the affected with an unaffected limb
to evaluate management interventions. This assumes
that if girth difference is stable, the unaffected limb
can be used as a control for comparison during nor-
mal growth. However often in pediatric lymphoedema
both lower limbs are affected and post-cancer adult
arm lymphoedema studies have reported that when
lymphoedema is present in the limb of the operated
side, subclinical changes occur in the limb of the un-
operated side [12, p. 283][30]. Although this may only
apply to the post-operative state, the validity of using
measures of the unaffected limb as a control is con-
testable. Moreover comparisons over time in pediatric
lymphoedema are not useful due to the natural changes
in length and circumference, rendering volumetrymea-
sures not appropriate [2].
Due to the challenges posed by growth, Hassall et
al. [25] proposed a ratio of foot to thigh volume to
assess change in limb volume in children with bilat-
eral lymphoedema. Unfortunately the calculation was
not provided in the publication and there is no way
to assess the validity of the calculation used or re-
produce the method. The authors were unable to find
any further reference to this method in later pediatric
literature. The use of a ratio warrants further investi-
gation, as it is a plausible method to monitor change
within a limb in a growing child or where bilateral lym-
phoedema is present.
Despite the suggested differences in pediatric lym-
phoedema presentation the research about pediatric
lymphoedema management has mostly assessed the
outcomes of adult management practices based on the
outcomes of secondary lymphoedema research [2,31,
32]. Historic literature recommends the use of com-
pression using garments or bandaging [3,8,9]; although
the style and options for application of compression
have changed over time, its use has been consistent in
the management of lymphoedema. Single use cohesive
bandages changed only two or three times per week,
and padded systems that may be re-used are now avail-
able for use clinically compared with traditional short-
stretch elastic bandages changed daily. Pneumatic
compression has evolved from being non-segmented
and beginning distally [9,21] to a segmented, sequen-
tial application [22,25]. The use of pneumatic com-
pression devices varies considerably globally: in some
countries it is used as standard treatment in home pro-
grams; in other countries it is a novel treatment modal-
ity or compression whether pneumatic or not, is un-
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available due to factors of cost and availability. Five
studies in this review (retrospective, prospective and
case study) assessed pneumatic compression and all
reported favorable outcomes without adverse effects
in the management of pediatric lymphoedema. While
larger, more robust research, which defines optimal ap-
plication parameters is required, it appears that pneu-
matic compression is useful in the management of pe-
diatric lymphoedema.
A novel approach using cervical stimulation for the
management of pediatric lymphoedema has been in-
vestigated [19]. Although positive outcomes were re-
ported, some participants were concurrently prescribed
compression garments to manage fibrosis noted in the
limb [19] and the outcomes of treatment may not be a
direct result of the stimulation.
The first trials of low level laser therapy (LLLT)
for lymphoedema management were published in
1998 [33]. Since then there have been favorable reports
regarding its use in the management of breast cancer
related lymphoedema (BCRL) [34–36]. Only one case
study (N= 1) has investigated the use of LLLT for pri-
mary, pediatric lymphoedema [23]. While the outcome
was positive and there were no adverse effects, further
research is required.
While it is reassuring that no adverse effects from
adult management strategies were reported, the litera-
ture did not provide evidence that current, adult based
management interventions are providing optimal out-
comes for children. Further research is needed to de-
termine if the different precipitator of lymphoedema
in different age groups (congenital versus trauma) re-
quires a different treatment approach. No studies were
identified that compared adult and pediatric outcomes
using the same management.
Seven studies in this review cited the prevalence of
primary lymphoedema from Smeltzer et al. [9] who
calculated an incidence rate of 1.15/100,000 popula-
tion less than age 20 years. This rate was based on one
town that over the study period (1955–1974) had an
average population of 17,800 people. Four diagnoses
of primary lymphoedemawere made during the twenty
years of this study and from this, an incidence rate was
calculated. The external validity of extrapolating these
figures as the prevalence worldwide and over time is
questionable.
Many interventions described in this review required
substantial and ongoing parental time and significant
costs were likely to have been incurred where thera-
pist intervention was provided on a daily basis [19,
20,24,25]. As the number of working mothers has in-
creased the impost of attending treatment, and its im-
pact on employment as well as the ongoing time com-
mitment to supervise and deliver home therapy may
contribute to increased family distress. The psycholog-
ical impact of pediatric lymphoedema on families has
been reported [4,5] and the financial and time costs
of treatment which contribute to this impact, has been
noted in pediatric chronic illness [37]. Further, access
to pediatric services in Australia is limited to a few spe-
cialist centers and small numbers of therapists. Poor
access to treatment and limited services underpin the
need for efficient evidence based practice in order to
minimize the burden of treatment on families and opti-
mize self-management.
8. Limitations of this systematic review
This review did not include languages other than En-
glish; however the use of broad search terms, examina-
tion of study reference lists and unrestricted dates pro-
vides confidence in the rigor of this English language
review.
9. Conclusion
Limited, poor quality evidence is available to guide
management of pediatric lymphoedema. This review
has found limited evidence to support the use of com-
pression therapy, including the use of pneumatic com-
pression, in pediatric lymphoedema; however specific
parameters for application of compression are un-
able to be provided. While descriptive studies report
differences in pediatric and adult lymphoedema pre-
sentation, there is no research that has investigated
the response of different age groups within the lym-
phoedema community to the same intervention and no
large scale, high quality studies to evaluate interven-
tions commonly used in the management of pediatric
lymphoedema. This research is vital to ensure treat-
ment resources are efficiently allocated and provide
optimal outcomes for children with lymphoedema.
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